Transit Alert: SEPTA is cutting bus, subway, and rail service across Philadelphia. These changes may affect patients, visitors, and staff traveling to and from Fox Chase Cancer Center locations. Read full update.
Harbour BioMed
Shanghai, China
Harbour BioMed and Fox Chase Cancer Center initiated discussions related to opening clinical trials at Fox Chase using Harbour BioMed’s candidate oncology agents. Harbour BioMed is a global, clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology and inflammatory diseases. Harbour BioMed’s current portfolio includes four clinical-stage in-licensed compounds and a rapidly emerging set of therapeutics coming from its internal discovery efforts as well as co-discovery/development collaborations with academic institutions and biopharmaceutical companies.
About Our Agreement
Confidentiality Agreement - details are confidential and cannot be disclosed to the public.
